A gene therapy recently approved by the FDA to treat patients with Sickle Cell Anemia is now being administered in St. Louis.

Beam Therapeutics and Verve Therapeutics have each built their lead candidates on a technique billed as a safer alternative ...

Representatives from the American Red Cross and Vitalant Blood Donation hosted organization leaders on campus for an ...

Immune system scientists and computational biologists are developing a new tool to investigate how the body fights disease.